151 related articles for article (PubMed ID: 25608636)
1. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
[TBL] [Abstract][Full Text] [Related]
2. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
[TBL] [Abstract][Full Text] [Related]
3. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
Zhao H; Zhu F; Sun J; Meng X
Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
[TBL] [Abstract][Full Text] [Related]
5. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
7. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
8. NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.
Stoehr CG; Nolte E; Wach S; Wieland WF; Hofstaedter F; Hartmann A; Stoehr R
Int J Mol Sci; 2012; 13(9):10959-10969. PubMed ID: 23109831
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
Wang XC; Wang J; Tao HH; Zhang C; Xu LF
Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
[TBL] [Abstract][Full Text] [Related]
10. Association of NAD (P) H Quinine Oxidoreductase 1 rs1800566 Polymorphism with Bladder and Prostate Cancers - a Systematic Review and Meta-Analysis.
Abedinzadeh M; Moghimi M; Dastgheib SA; Maleki H; Salehi E; Zare M; Jarahzadeh HM; Neamatzadeh H
Klin Onkol; 2020; 33(2):92-100. PubMed ID: 32303129
[TBL] [Abstract][Full Text] [Related]
11. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
12. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
[TBL] [Abstract][Full Text] [Related]
13. Association between NQO1 C609T polymorphism and colorectal cancer risk.
Wang Y; Zhang G; Luo Y
Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
[TBL] [Abstract][Full Text] [Related]
14. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
15. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
Guo ZJ; Feng CL
Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
[TBL] [Abstract][Full Text] [Related]
16. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis.
Lajin B; Alachkar A
Br J Cancer; 2013 Sep; 109(5):1325-37. PubMed ID: 23860519
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
Mandal RK; Dubey S; Panda AK; Mittal RD
Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
[TBL] [Abstract][Full Text] [Related]
18. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
[TBL] [Abstract][Full Text] [Related]
19. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
[TBL] [Abstract][Full Text] [Related]
20. An association between NQO1 genetic polymorphism and risk of bladder cancer.
Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
